Nor-1, a novel incretin-responsive regulator of insulin genes and insulin secretion

• Published in: Molecular metabolism (Germany) Vol. 2; no. 3; pp. 243 - 255
• Main Authors: Ordelheide, Anna-Maria, Gerst, Felicia, Rothfuss, Oliver, Heni, Martin, Haas, Carina, Thielker, Inga, Herzberg-Schäfer, Silke, Böhm, Anja, Machicao, Fausto, Ullrich, Susanne, Stefan, Norbert, Fritsche, Andreas, Häring, Hans-Ulrich, Staiger, Harald
• Format: Journal Article
• Language: English
• Published: Germany Elsevier GmbH 01.08.2013; Elsevier
• Subjects: Endocrinology & Metabolism; Incretin resistance; Insulin gene expression; Insulin secretion; Nor-1; Original; TCF7L2; Insulin gene expression; TCF7L2; Nor-1; Incretin resistance; Insulin secretion
• ISSN: 2212-8778; 2212-8778
• DOI: 10.1016/j.molmet.2013.06.003

Abstract B-cell failure at the onset of type 2 diabetes is caused by a decline in β-cell function in the postprandial state and loss of pancreatic β-cell mass. Recently, we showed an association between increased insulin secretion and a single nucleotide polymorphism (SNP), SNP rs12686676, in the NR4A3 gene locus encoding the nuclear receptor Nor-1. Nor-1 is expressed in β-cells, however, not much is known about its function with regard to insulin gene expression and insulin secretion. Nor-1 is induced in a glucose-/incretin-dependent manner via the PKA pathway and directly induces insulin gene expression. Additionally, it stimulates insulin secretion possibly via regulation of potentially important genes in insulin exocytosis. Moreover, we show that the minor allele of NR4A3 SNP rs12686676 fully rescues incretin resistance provoked by a well-described polymorphism in TCF7L2 . Thus, Nor-1 represents a promising new target for pharmacological intervention to fight diabetes.